4CPS-150 Use of adalimumab for hidradenitis suppurativa

BACKGROUND: Adalimumab is an antibody against tumour necrosis factor-α currently indicated for moderate to severe hidradenitis suppurative (HS). PURPOSE: To assess the effectiveness and safety of adalimumab in patients with HS. MATERIAL AND METHODS: A retrospective study of patients with HS and trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Gil-Sierra, MD, Garciadeparedes-Esteban, JC, Rios-Sanchez, E, Briceño-Casado, MDP, Palomo-Palomo, C, Diaz-Navarro, J, Rey, EJ Alegre-Del, Martinez-Diaz, C, Lopez-Vallejo, JF, Borrero-Rubio, JM
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535183/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.241
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados